H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) shares crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares traded.
H. Lundbeck A/S Stock Performance
The company has a market capitalization of $21.91 billion, a P/E ratio of 25.00 and a beta of 0.68. The business has a 50-day moving average of $22.00 and a 200-day moving average of $22.00. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.15 and a quick ratio of 0.71.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Further Reading
- Five stocks we like better than H. Lundbeck A/S
- 10 Best Airline Stocks to Buy
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Market Cap Calculator: How to Calculate Market Cap
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- 3 Stocks to Consider Buying in October
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
